ISRG — Evaluation History

Intuitive Surgical, Inc.
Deterministic Evaluations last 3 months
1 records
Date Strategy Price Decision Conf Tech Macro Sector Earn Regime Rationale
11 Mar 2026 SectorRotationLLM $0.00 BUY 74% 0 0 0 0 Neutral [Healthcare] ISRG has broken out of a tight 8-week consolidation just above its rising 50-day moving average, with the 50-day now crossed back above the 200-day forming a fresh golden cross signal. Catalyst: Continued global rollout of the da Vinci 5 robotic surgical system, particularly international expansion into Europe and Asia-Pacific, represents a multi-year growth driver; any incremental FDA clearance for new procedure indications in Q2 2026 could provide an additional upside catalyst.
AI Evaluations last 3 months
0 records

No AI evaluations in the last 3 months.

An error has occurred. This application may no longer respond until reloaded. Reload 🗙